review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Salem Chouaib | Q98108267 |
P2093 | author name string | Stéphane Terry | |
Stéphanie Buart | |||
P2860 | cites work | Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1. | Q39063349 |
Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells | Q39282438 | ||
Hypoxia induces escape from innate immunity in cancer cells via increased expression of ADAM10: role of nitric oxide | Q39456593 | ||
Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. | Q39496267 | ||
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. | Q39507131 | ||
The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. | Q39876494 | ||
EMT in immuno-resistance | Q43141024 | ||
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? | Q51239492 | ||
Acquisition of tumor cell phenotypic diversity along the EMT spectrum under hypoxic pressure: Consequences on susceptibility to cell-mediated cytotoxicity. | Q53399279 | ||
Divergent effects of hypoxia on dendritic cell functions | Q56942671 | ||
Hypoxia-Inducible Factors and the Response to Hypoxic Stress | Q24629323 | ||
Targeting hypoxic response for cancer therapy | Q26767351 | ||
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer | Q26829571 | ||
Hypoxia-inducible factors in physiology and medicine | Q27013770 | ||
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia | Q28085029 | ||
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics | Q29615944 | ||
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia | Q30554443 | ||
PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation | Q33569771 | ||
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. | Q33588105 | ||
New insights into the role of EMT in tumor immune escape. | Q33869781 | ||
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment | Q34243443 | ||
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA. | Q34519307 | ||
Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes | Q34568910 | ||
Hypoxia-inducible factors, stem cells, and cancer | Q34625782 | ||
Targeting HIF1α eliminates cancer stem cells in hematological malignancies. | Q34887224 | ||
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. | Q35837701 | ||
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors | Q36137576 | ||
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells | Q36300305 | ||
Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa | Q36339991 | ||
The multifaceted role of autophagy in tumor evasion from immune surveillance | Q37109549 | ||
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 | ||
ITPRs/inositol 1,4,5-trisphosphate receptors in autophagy: From enemy to ally | Q38570193 | ||
Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis | Q38797313 | ||
EMT: 2016. | Q38883448 | ||
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells. | Q38911110 | ||
ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy | Q38949623 | ||
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells | Q39043650 | ||
P921 | main subject | hypoxia | Q105688 |
P304 | page(s) | 1625 | |
P577 | publication date | 2017-11-24 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Hypoxic Stress-Induced Tumor and Immune Plasticity, Suppression, and Impact on Tumor Heterogeneity | |
P478 | volume | 8 |
Q96155624 | Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups |
Q58768316 | Chemokine Receptors and Exercise to Tackle the Inadequacy of T Cell Homing to the Tumor Site |
Q61797406 | Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery |
Q92874681 | Hepatic Tumor Microenvironments and Effects on NK Cell Phenotype and Function |
Q59136348 | Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration |
Q94503539 | Hypoxia increases mutational load of breast cancer cells through frameshift mutations |
Q92637526 | MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential |
Q64102265 | Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors |
Q90697892 | Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape |
Q57296955 | Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity |
Q90293432 | The Air Sac Primordium of Drosophila: A Model for Invasive Development |
Q107670795 | The regulation of immune checkpoints by the hypoxic tumor microenvironment |
Search more.